What Is Insurtech and Why Is It Reshaping the UK Insurance Market?

Insurtech has transitioned from a buzzword to infrastructure.

In the insurance world – what began as a handful of consumer apps promising to make buying insurance less painful has become a structural force across underwriting, distribution and claims.

For anyone assessing the UK insurance market today, whether as an investor, an operator or a founder – insurtech is no longer a segment to watch from the sidelines. Insurtech is the evolved state of what we know the industry to be.

What is Insurtech?

Insurtech refers to technology-driven innovation applied to insurance: product design, distribution, underwriting and claims. It is not a single business model, and it is not the equivalent of a “digital insurer.”

An Insurtech can be a direct-to-consumer brand, a pricing engine sold into incumbents, a claims automation platform, or a Managing General Agent (MGA) whose primary advantage is data and software rather than capital.

This distinction matters. It’s not just about adding a portal or an app, it’s about changing how a risk gets priced or a claim gets settled.

Insurtech that stops at surface-level tooling, without touching how pricing or claims decisions get made, delivers far less than the label suggests.

Why Insurtech It Matters Now in the UK

The case for insurtech has always rested on a simple observation: legacy insurer infrastructure is slow to change.

Core systems that were built decades ago like: actuarial processes designed around annual pricing cycles, and underwriting workflows that depend on manual referral all constrain how quickly an insurer can respond to a shifting risk landscape or a competitor’s product.

Technology addresses this in three specific ways by enabling:

• Faster product iteration, so a new proposition can go from concept to market in weeks rather than the multi-year cycles typical of a legacy carrier.
• Richer data, allowing pricing decisions to draw on far richer and more current inputs than the static rating factors many incumbent books still rely on.
• More efficient distribution, removing layers of manual handling between a risk and the capacity that ultimately backs it.

None of this makes insurtech a guaranteed advantage.

Historically, there are plenty of businesses in the sector that scaled distribution without matching underwriting discipline and paid for it.

However, where the two are combined, the speed advantage over legacy infrastructure is real. In a market under margin pressure, the benefits are becoming difficult for incumbents to ignore.

The MGA Model as an Insurtech Enabler

One of the best examples of insurtech in the UK market is its convergence with the MGA model.

A managing general agent operates under delegated underwriting authority from an insurer or Lloyd’s syndicate, which means it can build a leaner operation than a full-stack carrier.

It does not need to hold its own regulatory capital against the risks it writes, which allows for investment in underwriting expertise, data and technology instead. This kind of structure is well suited to an insurtech.

An MGA backed by strong data and software can iterate its pricing and appetite far faster than a traditional carrier encumbered by legacy systems and broader product lines, while a capacity provider carries the underlying balance sheet risk.

It’s a clear division of labour: the insurer provides the capital and carries the balance sheet risk on one side, while the MGA has the delegated underwriting authority to place complex risk, and the speed to apply it.

This is one reason capital has been moving toward MGA-led insurtech models rather than full-stack insurance start-ups. Building and holding underwriting risk is capital-intensive and slow to prove out.

Building specialist underwriting expertise on top of someone else’s capacity is faster to market and, done well, gives your business a competitive edge.

An example of this kind of insurtech company in the UK is Exance – an MGA in our own portfolio operating across property, construction and financial lines.

Exance’s advantage is not a large balance sheet; it is delegated underwriting authority to place complex, often under-served risk categories, supported by the technology and operational infrastructure that allows it to make decisions quickly.

This combination of specialist expertise and lean, technology-enabled infrastructure, is one working example of what insurtech looks like when real underwriting is applied instead of pure distribution.

The UK Insurtech Market

The UK’s position in insurtech is not accidental.

London remains one of the world’s principal centres for specialty insurance, built around the Lloyd’s of London and the depth of underwriting, broking and capacity expertise it houses.

This level of expertise gives UK insurtechs access to capacity providers and technical talent that few other markets can match.

Lloyd’s has the institutional infrastructure to support the transition. The Lloyd’s Lab, its innovation accelerator, runs structured cohorts connecting insurtech founders directly with underwriters and market participants.

It has become a recognised route for early-stage insurtechs to gain traction inside the Lloyd’s market rather than trying to break in from outside.

Regulation also plays a role. The Financial Conduct Authority’s regulatory sandbox allows new insurance propositions to test with real customers under supervision before scaling fully, which has made the UK a more practical launch market than jurisdictions with less flexible regimes.

At the same time, the FCA’s expanded review of delegated authority and remuneration arrangements, running from Q2 2026 with findings due in early 2027, has raised the bar for what a credible insurtech or MGA now needs to demonstrate under the Consumer Duty.

What Accquis Is Doing in This Space

We approach insurtech from the underwriting side rather than the pure technology side.

Our investment is directed at specialist MGAs and insurtech businesses where the opportunity is to combine genuine underwriting expertise with the data and infrastructure to deploy it faster, rather than at consumer-facing distribution plays competing primarily on marketing spend.

This is not limited to new deals: we have committed £50 million to digital and data-driven initiatives across our existing portfolio and focus on upgrading the technology and analytics capability behind established businesses rather than treating insurtech investment as something that only applies at the point of acquisition.

Exance is one expression of that approach within our portfolio.

More broadly, we provide capital and operational support to high-growth insurance start-ups and established brokers.

Instead of businesses having to build data, compliance and technology capability from scratch, we provide the infrastructure to help the specialist underwriting expertise within the MGA model scale.

If you are building or backing a specialist MGA or insurance technology business in the UK, you can learn more about our approach and how we work with founders and management teams at this growth stage.

If you’re building or backing a specialist MGA and want a capital partner who understands the underwriting side, the technology story, and everything in between, let’s talk. Accelerate your growth. Apply for funding today.